Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Methods of reducing fever

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:

Yellow Fever

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...

Inhibitors of Viral Protein Synthesis

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...

Inhibitors Of Virion Release

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...

Inhibitors of Virion Maturation and Assembly

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Lost in translation: interferon-stimulated genes targeting flavivirus protein synthesis.

Journal of virology·2026

Same author

SAMD9L inhibits flavivirus translation independently of its capacity to trigger innate immune response.

PLoS pathogens·2025

Same author

Zika Virus: A Tale of Two Lineages.

Pathogens (Basel, Switzerland)·2025

Same author

[MITD1 inhibits the replication of neurotropic flaviviruses in microglial cells].

Medecine sciences : M/S·2025

Same author

African strains of Zika virus resist ISG-mediated restriction.

PLoS neglected tropical diseases·2025

Same author

MITD1 is a brain-specific interferon-inducible factor that inhibits flavivirus replication.

Proceedings of the National Academy of Sciences of the United States of America·2025

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

TRIMming down Flavivirus Infections.

Marion Cannac¹, Sébastien Nisole¹

¹Institut de Recherche en Infectiologie de Montpellier (IRIM), Université de Montpellier, CNRS, 34090 Montpellier, France.

|August 29, 2024

Summary

Flaviviruses, like dengue and Zika, are spreading globally. This review explores how tripartite motif (TRIM) proteins, part of the innate immune system, fight these viral infections.

Keywords:

TRIM proteins antiviral innate immunity flaviviruses interferon response restriction factors

More Related Videos

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

Related Experiment Videos

Last Updated: Jun 19, 2026

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses

Published on: January 20, 2017

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods

Published on: December 21, 2019

Area of Science:

Virology
Immunology
Molecular Biology

Background:

Flaviviruses are a growing global health threat, transmitted by arthropods like mosquitoes and ticks.
Mosquito-borne flaviviruses include dengue, Zika, and West Nile viruses, causing significant human disease.
Tick-borne flaviviruses are also an emerging concern.

Purpose of the Study:

To review the complex interactions between flaviviruses and tripartite motif (TRIM) proteins.
To elucidate the roles of TRIM proteins in innate immunity against flaviviruses.
To summarize viral strategies for evading or utilizing TRIM proteins.

Main Methods:

Review of existing scientific literature on flavivirus-TRIM interactions.
Analysis of direct and indirect antiviral mechanisms mediated by TRIM proteins.
Examination of viral counter-strategies against TRIM proteins.

Main Results:

Type I interferon-induced genes (ISGs) are crucial for innate antiviral defense.
Certain TRIM proteins are identified as ISGs that inhibit flavivirus replication.
TRIM proteins exhibit diverse functions, including direct viral inhibition and regulation of interferon response.

Conclusions:

Flaviviruses interact with TRIM proteins through various direct and indirect mechanisms.
Viruses have evolved strategies to counteract or exploit TRIM proteins for their replication.
Understanding these interactions is key to developing new antiviral therapies.